GPC3 and COVID-19: Our clinical observations indicate that delayed SGB, such as in individuals with long-standing analogous post-viral ailments (Lyme disease, chronic fatigue syndrome, and myalgic encephalopathy), exhibited notably diminished responsiveness to SGB as compared to long COVID-19 patients.